Betrixaban

CHEMBL512351 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
451.9 g/mol
LogP
3.6
Phase
4

An oral anticoagulant belonging to the factor Xa inhibitor class, used to prevent blood clots in hospitalized patients at risk for venous thromboembolism. It works by blocking factor Xa, a key enzyme in the blood clotting cascade. Its extended half-life allows for once-daily dosing.

น้ำหนักโมเลกุล

451.9000 g/mol

LogP

3.60

TPSA

107.00 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1

InChI

InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)

Molecular Formula

C23H22ClN5O3

HBD / HBA

3 / 5

พันธะที่หมุนได้

7

อะตอมหนัก

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An oral anticoagulant belonging to the factor Xa inhibitor class, used to prevent blood clots in hospitalized patients at risk for venous thromboembolism. It works by blocking factor Xa, a key enzyme in the blood clotting cascade. Its extended half-life allows for once-daily dosing.

Yes, Betrixaban is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL512351. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10275777. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.